PCV72 COST-EFFECTIVENESS ANALYSIS OF ADD-ON ALISKIREN TO LOSARTAN TREATMENT FOR PATIENTS WITH TYPE 2 DIABETES, HYPERTENSION AND NEPHROPATHY IN THE CZECH PATIENTS FROM PAYOR PERSPECTIVE

Effectiveness Analysis ◽

Payor Perspective ◽

Losartan Treatment

PDB3 COST-EFFECTIVENESS ANALYSIS OF INSULIN DETEMIR COMPARED TO NPH INSULIN IN PATIENTS WITH TYPE-2 DIABETES IN THE UNITED KINGDOM

Value in Health ◽

10.1016/s1098-3015(10)65946-3 ◽

2004 ◽

Vol 7 (6) ◽

pp. 735-736

Author(s):

I Smith ◽

AJ Palmer ◽

S Roze ◽

T Kennedy-Martin

Keyword(s):

Type 2 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Insulin Detemir ◽

Nph Insulin ◽

The United Kingdom ◽

PDB32 A LONG-TERM Cost-Effectiveness Analysis of Treatments for Type 2 Diabetes in Portugal: Once-Weekly Semaglutide 1 MG Versus Once-Daily Empagliflozin 25 MG

Value in Health ◽

10.1016/j.jval.2020.08.629 ◽

2020 ◽

Vol 23 ◽

pp. S511

Author(s):

N. Hallén ◽

D. Carvalho ◽

C. Costa ◽

B. Hunt

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Once Daily ◽

Cost Effectiveness Analysis of Flash Glucose Monitoring for Type 2 Diabetes Patients Receiving Insulin Treatment In The Uk

Value in Health ◽

10.1016/j.jval.2014.08.730 ◽

2014 ◽

Vol 17 (7) ◽

pp. A351 ◽

Cited By ~ 1

Author(s):

H. Li ◽

S.P. Bilir ◽

P. Donga ◽

A. Samiian ◽

J. Munakata

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Treatment ◽

Glucose Monitoring ◽

Flash Glucose Monitoring ◽

Effectiveness Analysis ◽

The Uk ◽

Diabetes Patients

Cost Effectiveness Analysis of a Hypertension Management Program in Patients With Type 2 Diabetes

Journal of Clinical Hypertension ◽

10.1111/j.1751-7176.2009.00082.x ◽

2009 ◽

Vol 11 (3) ◽

pp. 116-124 ◽

Cited By ~ 7

Author(s):

David Ly ◽

Fu Z. Alex ◽

Hebert Christopher

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Management Program ◽

Hypertension Management ◽

PDB24 COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO BIPHASIC INSULIN ASPART 30 FROM BIPHASIC HUMAN INSULIN 30 IN THE CZECH SETTING

Value in Health ◽

10.1016/s1098-3015(10)75002-6 ◽

2009 ◽

Vol 12 (7) ◽

pp. A405-A406

Author(s):

E Suchankova ◽

T Doležal ◽

Z Pisarikova ◽

K Rychna ◽

D Bartaskova

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Effectiveness Analysis ◽

Biphasic Insulin Aspart 30

Cost-Effectiveness Analysis of Exenatide versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus

PharmacoEconomics - Open ◽

10.1007/s41669-019-0171-y ◽

2019 ◽

Vol 4 (2) ◽

pp. 277-286 ◽

Cited By ~ 1

Author(s):

Margarita Capel ◽

Andreea Ciudin ◽

María Mareque ◽

Raquel María Rodríguez-Rincón ◽

Susana Simón ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cost Effectiveness ◽

Receptor Agonists ◽

Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease

Diabetes Therapy ◽

10.1007/s13300-019-00701-3 ◽

2019 ◽

Vol 10 (6) ◽

pp. 2153-2167 ◽

Cited By ~ 7

Author(s):

Mafalda Ramos ◽

Volker Foos ◽

Anastasia Ustyugova ◽

Nikco Hau ◽

Pranav Gandhi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Cost Effectiveness ◽

Cardiovascular Outcome ◽

Cardiovascular Outcome Trials ◽

PDB67 - ONCE-WEEKLY SEMAGLUTIDE VERSUS DULAGLUTIDE FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES IN PORTUGAL: A LONG-TERM COST-EFFECTIVENESS ANALYSIS BASED ON SUSTAIN 7

Value in Health ◽

10.1016/j.jval.2018.09.772 ◽

2018 ◽

Vol 21 ◽

pp. S129

Author(s):

S.J. Malkin ◽

D.G. Belbute ◽

B. Hunt ◽

C.S. Hoxer ◽

V. Martín

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

SAT-296 COST-EFFECTIVENESS ANALYSIS OF EMPAGLIFLOZIN TREATMENT IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE BASED ON SUBGROUP OF EMPA-REG OUTCOME

Kidney International Reports ◽

10.1016/j.ekir.2019.05.336 ◽

2019 ◽

Vol 4 (7) ◽

pp. S132

Author(s):

O.S. Reifsnider ◽

A. Kansal ◽

C. Wanner ◽

J. Lee ◽

E. Pfarr ◽

...

Keyword(s):

Type 2 Diabetes ◽

Chronic Kidney Disease ◽

Cost Effectiveness ◽

Kidney Disease ◽

Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis

BMJ ◽

10.1136/bmj.39545.585289.25 ◽

2008 ◽

Vol 336 (7654) ◽

pp. 1180-1185 ◽

Cited By ~ 160

Author(s):

Clare L Gillies ◽

Paul C Lambert ◽

Keith R Abrams ◽

Alex J Sutton ◽

Nicola J Cooper ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Effectiveness Analysis ◽

Screening And Prevention